BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10425273)

  • 1. P53 codon 72Arg polymorphism is not a risk factor for carcinogenesis in the chinese.
    Wang NM; Tsai CH; Yeh KT; Chen SJ; Chang JG
    Int J Mol Med; 1999 Sep; 4(3):249-52. PubMed ID: 10425273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of evidence that proline homozygosity at codon 72 of p53 and rare arginine allele at codon 31 of p21, jointly mediate cervical cancer susceptibility among Indian women.
    Bhattacharya P; Sengupta S
    Gynecol Oncol; 2005 Oct; 99(1):176-82. PubMed ID: 16054204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P53 codon 72 polymorphism as a risk factor in the development of HPV-associated cervical cancer.
    Dokianakis DN; Spandidos DA
    Mol Cell Biol Res Commun; 2000 Feb; 3(2):111-4. PubMed ID: 10775508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No evidence of correlation between polymorphism at codon 72 of p53 and risk of cervical cancer in Japanese patients with human papillomavirus 16/18 infection.
    Minaguchi T; Kanamori Y; Matsushima M; Yoshikawa H; Taketani Y; Nakamura Y
    Cancer Res; 1998 Oct; 58(20):4585-6. PubMed ID: 9788606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 codon 72 polymorphism and risk of cervical carcinoma in Korean women.
    Baek WK; Cho JW; Suh SI; Suh MH; Shin DH; Cho CH; Lee TS; Cha SD
    J Korean Med Sci; 2000 Feb; 15(1):65-7. PubMed ID: 10719811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 codon 72 polymorphism (C/G) and the risk of human papillomavirus-associated carcinomas in China.
    Li T; Lu ZM; Guo M; Wu QJ; Chen KN; Xing HP; Mei Q; Ke Y
    Cancer; 2002 Dec; 95(12):2571-6. PubMed ID: 12467072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Polymorphism in codon 72 of the p53 gene and cervico-uterine cancer risk in Mexico].
    Suárez-Rincón AE; Morán-Moguel MC; Montoya-Fuentes H; Gallegos-Arreola MP; Sánchez-Corona J
    Ginecol Obstet Mex; 2002 Jul; 70():344-8. PubMed ID: 12221910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer.
    Storey A; Thomas M; Kalita A; Harwood C; Gardiol D; Mantovani F; Breuer J; Leigh IM; Matlashewski G; Banks L
    Nature; 1998 May; 393(6682):229-34. PubMed ID: 9607760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of p53 codon 72 genotypes in human papillomavirus associated squamous intraepithelial lesions and cervical cancer.
    Szarka K; Veress G; Kónya J; Gergely L
    Anticancer Res; 1999; 19(3B):2377-9. PubMed ID: 10472360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Risk factors for cervico-uterine cancer associated to HPV: p53 codon 72 polymorphism in women attending hospital care].
    Sifuentes Alvarez A; Reyes Romero M
    Ginecol Obstet Mex; 2003 Jan; 71():12-5. PubMed ID: 12708345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of TP53 codon 72 polymorphism with cervical cancer risk in Chinese women.
    Jiang P; Liu J; Zeng X; Li W; Tang J
    Cancer Genet Cytogenet; 2010 Mar; 197(2):174-8. PubMed ID: 20193851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No relationship observed between human p53 codon-72 genotype and HPV-associated cervical cancer in a population group with a low arginine-72 allele frequency.
    Govan VA; Loubser S; Saleh D; Hoffman M; Williamson AL
    Int J Immunogenet; 2007 Jun; 34(3):213-7. PubMed ID: 17504512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The p53 Arg72Pro polymorphism, human papillomavirus, and invasive squamous cell cervical cancer.
    Madeleine MM; Shera K; Schwartz SM; Daling JR; Galloway DA; Wipf GC; Carter JJ; McKnight B; McDougall JK
    Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):225-7. PubMed ID: 10698487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphism at codon 72 of p53 is not associated with cervical cancer risk.
    Malcolm EK; Baber GB; Boyd JC; Stoler MH
    Mod Pathol; 2000 Apr; 13(4):373-8. PubMed ID: 10786802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 polymorphism in human papillomavirus-associated esophageal cancer.
    Kawaguchi H; Ohno S; Araki K; Miyazaki M; Saeki H; Watanabe M; Tanaka S; Sugimachi K
    Cancer Res; 2000 Jun; 60(11):2753-5. PubMed ID: 10850407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus and p53 polymorphism in codon 72 in head and neck squamous cell carcinoma.
    Hoffmann M; Scheunemann D; Fazel A; Görögh T; Kahn T; Gottschlich S
    Oncol Rep; 2009 Mar; 21(3):809-14. PubMed ID: 19212643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of p53 arginine polymorphism with skin cancer.
    de Oliveira WR; Rady PL; Grady J; Hughes TK; Neto CF; Rivitti EA; Tyring SK
    Int J Dermatol; 2004 Jul; 43(7):489-93. PubMed ID: 15230885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arginine and proline alleles of the p53 gene are associated with different locations of gastric cancer.
    Lai KC; Chen WC; Tsai FJ; Li SY; Jeng LB
    Hepatogastroenterology; 2005; 52(63):944-8. PubMed ID: 15966238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P53 codon 72 polymorphism in breast cancer.
    Buyru N; Tigli H; Dalay N
    Oncol Rep; 2003; 10(3):711-4. PubMed ID: 12684648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethnic variation of the P53 codon 72 polymorphism, HPV persistence, and cervical cancer risk.
    Inserra P; Abrahamsen M; Papenfuss M; Giuliano AR
    Int J STD AIDS; 2003 Dec; 14(12):800-4. PubMed ID: 14678586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.